Calcium channel inhibition promotes cardiac regeneration, offering hope for heart failure treatment

Calcium channel inhibition promotes cardiac regeneration, offering hope for heart failure treatment

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in npj Regenerative Medicine, the study reveals a novel approach to promoting cardiomyocyte proliferation. The researchers are from the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions.

New research provides hope for ischemic heart failure treatment

The study demonstrates that both pharmacological and genetic inhibition of LTCC can induce cardiomyocyte replication and that this occurs by modulating the activity of calcineurin, a known regulator of cardiomyocyte proliferation.

Breakthrough research offers hope for treatment of ischemic heart failure

New York: A global team of researchers has reported a groundbreaking discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in the journal npj Regenerative Medicine, the study by Baylor College of Medicine in the US, the QIMR Berghofer Medical Research Institute in Brisbane, Australia, and collaborating institutions reveals a novel approach to promoting cardiomyocyte proliferation. “When the…

SeamlessMD digital app providing heart failure patients with at-home resources and improving care - Horizon Health Network

(HORIZON) – Horizon is expanding the availability of a leading Canadian-made digital application, SeamlessMD, that allows patients diagnosed with heart failure to access helpful resources from their mobile device, improving their treatment experience. The expansion, which launched in February, allows patients diagnosed with heart failure and receiving treatment from a Horizon Heart Function Clinic to access the SeamlessMD app from their smartpho…